Background Analysis: US FDA Advisory Committee to Review Data Requirements for Food and Airborne Allergy Immunotherapies – JAN 21, 2016 (APAC)
The US FDA has scheduled an Allergenic Products Advisory Committee (APAC) Meeting for January 21, 2016. The Committee will discuss safety and effectiveness data, including challenge study endpoints, for licensure of food allergy immunotherapy products, and the clinical development of aeroallergen (airborne) immunotherapy products for the prevention of respiratory allergic disease.
See the SAC Tracker report